News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,196 Results
Type
Article (45576)
Company Profile (468)
Press Release (701135)
Multimedia
Podcasts (134)
Webinars (23)
Section
Business (209884)
Career Advice (2081)
Deals (36248)
Drug Delivery (130)
Drug Development (84397)
Employer Resources (175)
FDA (16896)
Job Trends (15284)
News (355660)
Policy (33554)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2693)
Accelerated approval (45)
Adcomms (29)
Allergies (165)
Alliances (51245)
ALS (202)
Alzheimer's disease (1804)
Antibody-drug conjugate (ADC) (392)
Approvals (17181)
Artificial intelligence (632)
Autoimmune disease (232)
Automation (50)
Bankruptcy (374)
Best Places to Work (11893)
BIOSECURE Act (20)
Biosimilars (207)
Biotechnology (329)
Bladder cancer (182)
Brain cancer (67)
Breast cancer (703)
Cancer (5469)
Cardiovascular disease (468)
Career advice (1764)
Career pathing (41)
CAR-T (311)
CDC (55)
Celiac Disease (2)
Cell therapy (841)
Cervical cancer (41)
Clinical research (72437)
Collaboration (2002)
Company closure (4)
Compensation (1307)
Complete response letters (81)
COVID-19 (2793)
CRISPR (107)
C-suite (1021)
Cystic fibrosis (159)
Data (7166)
Decentralized trials (3)
Denatured (43)
Depression (165)
Dermatology (58)
Diabetes (557)
Diagnostics (6902)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (313)
Drug pricing (207)
Drug shortages (30)
Duchenne muscular dystrophy (285)
Earnings (92450)
Editorial (64)
Employer branding (21)
Employer resources (154)
Events (122445)
Executive appointments (1068)
FDA (20376)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1687)
Gene editing (230)
Generative AI (54)
Gene therapy (716)
GLP-1 (1069)
Government (4819)
Grass and pollen (6)
Guidances (398)
Healthcare (19388)
HIV (75)
Huntington's disease (54)
IgA nephropathy (96)
Immunology and inflammation (300)
Immuno-oncology (87)
Indications (159)
Infectious disease (3113)
Inflammatory bowel disease (212)
Inflation Reduction Act (17)
Influenza (131)
Intellectual property (279)
Interviews (322)
IPO (16960)
IRA (53)
Job creations (3738)
Job search strategy (1466)
JPM (67)
Kidney cancer (18)
Labor market (93)
Layoffs (593)
Leadership (36)
Legal (8116)
Liver cancer (100)
Longevity (28)
Lung cancer (733)
Lymphoma (412)
Machine learning (53)
Management (59)
Manufacturing (943)
MASH (185)
Medical device (14132)
Medtech (14209)
Mergers & acquisitions (20454)
Metabolic disorders (1473)
mRNA (199)
Multiple sclerosis (179)
NASH (20)
Neurodegenerative disease (411)
Neuropsychiatric disorders (107)
Neuroscience (3270)
Neurotech (1)
NextGen: Class of 2026 (6840)
Non-profit (4624)
Now hiring (73)
Obesity (707)
Opinion (308)
Ovarian cancer (187)
Pain (249)
Pancreatic cancer (261)
Parkinson's disease (355)
Partnered (34)
Patents (560)
Patient recruitment (606)
Peanut (61)
People (60840)
Pharmaceutical (81)
Pharmacy benefit managers (33)
Phase 1 (22740)
Phase 2 (31909)
Phase 3 (23620)
Pipeline (7219)
Policy (321)
Postmarket research (2659)
Preclinical (9724)
Press Release (68)
Prostate cancer (285)
Psychedelics (57)
Radiopharmaceuticals (323)
Rare diseases (1068)
Real estate (6089)
Recruiting (72)
Regulatory (25674)
Reports (54)
Research institute (2521)
Resumes & cover letters (363)
Rett syndrome (32)
RNA editing (22)
RSV (85)
Schizophrenia (171)
Series A (284)
Series B (213)
Service/supplier (11)
Sickle cell disease (114)
Special edition (27)
Spinal muscular atrophy (169)
Sponsored (46)
Startups (3838)
State (2)
Stomach cancer (19)
Supply chain (121)
Tariffs (88)
The Weekly (88)
Vaccines (1099)
Venture capital (106)
Weight loss (456)
Women's health (112)
Worklife (20)
Date
Today (77)
Last 7 days (577)
Last 30 days (2549)
Last 365 days (30855)
2026 (8285)
2025 (31116)
2024 (36358)
2023 (41078)
2022 (52358)
2021 (56867)
2020 (55071)
2019 (47705)
2018 (35931)
2017 (33192)
2016 (32641)
2015 (38646)
2014 (32376)
2013 (27350)
2012 (29456)
2011 (30117)
2010 (28254)
Location
Africa (773)
Alabama (96)
Alaska (7)
Arizona (343)
Arkansas (15)
Asia (41212)
Australia (6879)
California (12517)
Canada (3545)
China (1271)
Colorado (533)
Connecticut (543)
Delaware (371)
Europe (90873)
Florida (1863)
Georgia (399)
Hawaii (3)
Idaho (62)
Illinois (984)
India (81)
Indiana (564)
Iowa (24)
Japan (494)
Kansas (133)
Kentucky (46)
Louisiana (39)
Maine (73)
Maryland (1510)
Massachusetts (9068)
Michigan (350)
Minnesota (690)
Mississippi (6)
Missouri (141)
Montana (35)
Nebraska (29)
Nevada (135)
New Hampshire (87)
New Jersey (3345)
New Mexico (31)
New York (3288)
North Carolina (1645)
North Dakota (9)
Northern California (6169)
Ohio (371)
Oklahoma (22)
Oregon (45)
Pennsylvania (2517)
Puerto Rico (26)
Rhode Island (51)
South America (1142)
South Carolina (77)
South Dakota (1)
Southern California (4903)
Tennessee (200)
Texas (1960)
United States (44490)
Utah (375)
Vermont (1)
Virginia (300)
Washington D.C. (81)
Washington State (1023)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
747,196 Results for "pain therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
New Painkillers Critical To Fight Opioid Epidemic, Broader Pain Crisis
Alternatives to opioids are desperately needed to better treat moderate to severe acute pain, but to date, we’ve seen few novel analgesics hit the market.
February 26, 2026
·
6 min read
·
James Hackworth
Press Releases
Nocion Therapeutics to Present Preclinical Data Supporting Nocions™ as a Novel Approach for the Treatment of Pain at the Non-Opioid Pain Therapeutics Summit
January 27, 2026
·
3 min read
Press Releases
Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain
March 31, 2026
·
5 min read
Press Releases
Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1
March 31, 2026
·
3 min read
Press Releases
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
October 8, 2025
·
4 min read
Pain
Lilly Refines Pain Pipeline Again, Scrapping Mid-Stage Program
Before being discontinued, the P2X7 receptor blocker had cleared a master protocol study in chronic pain, though Eli Lilly said that results were not sufficient for advancement of the Asahi Kasei–partnered asset.
October 31, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication
March 3, 2026
·
7 min read
Press Releases
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
February 1, 2026
·
12 min read
Press Releases
PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology
February 25, 2026
·
6 min read
Press Releases
Dogwood Therapeutics Announces Positive Interim Phase 2b Clinical Trial Results in Chemotherapy Induced Neuropathic Pain
December 23, 2025
·
5 min read
1 of 74,720
Next
